NCT01211314View on ClinicalTrials.gov

Antihypertensive Efficacy of Fixed Combination Drug

PHASE4TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

April 30, 2012

Conditions
Hypertension
Interventions
DRUG

Lercanidipine/enalapril fixed combination

Lercanidipine 10 mg + enalapril 20 mg, once a day, used as a fixed combination drug. Unique dose during the study

Trial Locations (1)

Unknown

Clalit Health Services, Herzliya

Sponsors
All Listed Sponsors
collaborator

Dexcel Pharma Technologies Ltd.

INDUSTRY

lead

Meir Medical Center

OTHER